SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T - Tender offer statement by Third Party [amend]
SEC Accession No. 0001193125-13-371936
Filing Date
2013-09-19
Accepted
2013-09-19 17:28:06
Documents
1
Filing Date Changed
2013-09-19
Group Members
ARENA ACQUISITION CO

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 TO SCHEDULE TO-T d598977dsctota.htm SC TO-T/A 25029
  Complete submission text file 0001193125-13-371936.txt   26711
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filed by) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000
ONYX PHARMACEUTICALS INC (Subject) CIK: 0001012140 (see all company filings)

IRS No.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-45955 | Film No.: 131106232
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1